Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

Richard D Moore, Craig R. Smith, Paul S. Lietman

Research output: Contribution to journalArticle

Abstract

To determine the association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia, the case reports of 37 patients from four prospective, randomized, controlled trials of gentamicin, tobramycin, and amikacin were analyzed. Twenty (54 percent) of these patients had a favorable outcome. Patients with maximal one-hour postinfusion (peak) levels of 7 μg/ml or greater for gentamicin and tobramycin or 28 μg/ml or greater for amikacin more often had successful outcomes (14 of 18, 78 percent) than those with levels less than this (six of 19, 32 percent) (p <0.006). Patients with overall mean peak levels of 6 μg/ml or greater for gentamicin and tobramycin or 24 μg/ml or greater for amikacin more often had successful outcomes (14 of 20, 70 percent) than those with levels less than this (six of 17, 35 percent) (p <0.04). The initial patient temperature, serum urea nitrogen/creatinine ratio, initial polymorphonuclear leukocyte count, and age were also associated with outcome; but by multivariate analysis, achieving an adequate peak concentration was the most important discriminating factor. These results suggest the potential importance of achieving adequate aminoglycoside levels in patients with gram-negative pneumonia.

Original languageEnglish (US)
Pages (from-to)657-662
Number of pages6
JournalAmerican Journal of Medicine
Volume77
Issue number4
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Aminoglycosides
Pneumonia
Tobramycin
Amikacin
Gentamicins
Therapeutics
Leukocyte Count
Urea
Creatinine
Neutrophils
Nitrogen
Multivariate Analysis
Randomized Controlled Trials
Temperature
Serum

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. / Moore, Richard D; Smith, Craig R.; Lietman, Paul S.

In: American Journal of Medicine, Vol. 77, No. 4, 1984, p. 657-662.

Research output: Contribution to journalArticle

@article{0944d3f331cf4a819d0cd2939619b0a2,
title = "Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia",
abstract = "To determine the association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia, the case reports of 37 patients from four prospective, randomized, controlled trials of gentamicin, tobramycin, and amikacin were analyzed. Twenty (54 percent) of these patients had a favorable outcome. Patients with maximal one-hour postinfusion (peak) levels of 7 μg/ml or greater for gentamicin and tobramycin or 28 μg/ml or greater for amikacin more often had successful outcomes (14 of 18, 78 percent) than those with levels less than this (six of 19, 32 percent) (p <0.006). Patients with overall mean peak levels of 6 μg/ml or greater for gentamicin and tobramycin or 24 μg/ml or greater for amikacin more often had successful outcomes (14 of 20, 70 percent) than those with levels less than this (six of 17, 35 percent) (p <0.04). The initial patient temperature, serum urea nitrogen/creatinine ratio, initial polymorphonuclear leukocyte count, and age were also associated with outcome; but by multivariate analysis, achieving an adequate peak concentration was the most important discriminating factor. These results suggest the potential importance of achieving adequate aminoglycoside levels in patients with gram-negative pneumonia.",
author = "Moore, {Richard D} and Smith, {Craig R.} and Lietman, {Paul S.}",
year = "1984",
doi = "10.1016/0002-9343(84)90358-9",
language = "English (US)",
volume = "77",
pages = "657--662",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

AU - Moore, Richard D

AU - Smith, Craig R.

AU - Lietman, Paul S.

PY - 1984

Y1 - 1984

N2 - To determine the association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia, the case reports of 37 patients from four prospective, randomized, controlled trials of gentamicin, tobramycin, and amikacin were analyzed. Twenty (54 percent) of these patients had a favorable outcome. Patients with maximal one-hour postinfusion (peak) levels of 7 μg/ml or greater for gentamicin and tobramycin or 28 μg/ml or greater for amikacin more often had successful outcomes (14 of 18, 78 percent) than those with levels less than this (six of 19, 32 percent) (p <0.006). Patients with overall mean peak levels of 6 μg/ml or greater for gentamicin and tobramycin or 24 μg/ml or greater for amikacin more often had successful outcomes (14 of 20, 70 percent) than those with levels less than this (six of 17, 35 percent) (p <0.04). The initial patient temperature, serum urea nitrogen/creatinine ratio, initial polymorphonuclear leukocyte count, and age were also associated with outcome; but by multivariate analysis, achieving an adequate peak concentration was the most important discriminating factor. These results suggest the potential importance of achieving adequate aminoglycoside levels in patients with gram-negative pneumonia.

AB - To determine the association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia, the case reports of 37 patients from four prospective, randomized, controlled trials of gentamicin, tobramycin, and amikacin were analyzed. Twenty (54 percent) of these patients had a favorable outcome. Patients with maximal one-hour postinfusion (peak) levels of 7 μg/ml or greater for gentamicin and tobramycin or 28 μg/ml or greater for amikacin more often had successful outcomes (14 of 18, 78 percent) than those with levels less than this (six of 19, 32 percent) (p <0.006). Patients with overall mean peak levels of 6 μg/ml or greater for gentamicin and tobramycin or 24 μg/ml or greater for amikacin more often had successful outcomes (14 of 20, 70 percent) than those with levels less than this (six of 17, 35 percent) (p <0.04). The initial patient temperature, serum urea nitrogen/creatinine ratio, initial polymorphonuclear leukocyte count, and age were also associated with outcome; but by multivariate analysis, achieving an adequate peak concentration was the most important discriminating factor. These results suggest the potential importance of achieving adequate aminoglycoside levels in patients with gram-negative pneumonia.

UR - http://www.scopus.com/inward/record.url?scp=0021221208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021221208&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(84)90358-9

DO - 10.1016/0002-9343(84)90358-9

M3 - Article

C2 - 6385693

AN - SCOPUS:0021221208

VL - 77

SP - 657

EP - 662

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 4

ER -